Discover the hidden signals beyond clinical trials that can help pharma teams evaluate future blockbuster drugs, from biomarkers and pipeline momentum to competitive intelligence.
The field of pharmaceutical innovation is rapidly growing and new drug candidates, biotechnology companies, clinical trials, scientific approaches are being added every day.
Learn how pharma companies can identify promising acquisition targets before Phase III by analyzing clinical trials, drug pipelines, biomarkers, scientific evidence, and strategic fit.
Discover why structured clinical trial data services and clinical trials solutions are now critical for pharma R&D, BD teams, and CROs competing in a complex drug development landscape.
Discover how Clinical Trial Intelligence is transforming the clinical drug development process, improving drug development decisions, and supporting smarter API drug development with real-time data and AI-driven insights.
Learn how better data helps pharmaceutical companies identify the right drug licensing opportunities through clinical drug development, development of drug insights, and API drug development intelligence.
The rate of innovation is impressive both in terms of the opportunities it offers, and in terms of the complexity with which strategic decisions have to be made.
Discover how Predictive Clinical Intelligence, AI, and real-time analytics are transforming clinical drug research, drug development clinical trial phases, and the phases of drug development to help pharmaceutical companies make faster, smarter decisions.
It's the structured path a molecule follows from lab to market: preclinical research, Phase I (safety), Phase II (efficacy and dosing), Phase III (large-scale confirmation), regulatory review, and Phase IV post-market monitoring. As of 2026, nearly half of the roughly 23,000 active global pipeline drugs are still in the preclinical stage alone.
Discover how AI, real-time API intelligence, phases of pharmaceutical development, and API clinical trial data are transforming pharmaceutical supply chains through smarter forecasting, risk management, and strategic decision-making.
1 September 2026
25 August 2026
18 August 2026
11 August 2026
5 August 2026
